GlassScriptPhysician profile
Christopher Aaron Dalby
NPI 1104329069
$4,426.89
in general payments reported to CMS, 2019-2025
31 companies · $851 in 2025
The $851 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $836 · 2023: $1,408 · 2024: $1,063 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,321.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,881.57 | 2021-2025 | Puraply, Novachor, Puraply Wound Matrix |
| Smith+Nephew, INC. | $979.62 | 2021-2025 | Grafix Pl, Stravix Pl, Stravix |
| Abbvie INC. | $323.74 | 2021-2025 | |
| Stryker Corporation | $170.92 | 2023-2025 | Augment Injectable, 7 X 23mm Citrelock Implant, Bioskin |
| Acera Surgical, INC. | $93.43 | 2025 | Restrata Wound Matrix |
| Convatec INC. | $81.26 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $80.70 | 2022-2023 | Seglentis |
| Bioventus LLC | $79.13 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $71.30 | 2021-2025 | Jublia |
| Kerecis Limited | $63.67 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $60.11 | 2022 | |
| Boston Scientific Corporation | $55.99 | 2025 | Wavewriter Alpha Prime 16 |
| Solventum Corporation | $45.30 | 2024-2025 | Activ.A.C. |
| Medtronic, INC. | $42.86 | 2023 | Intellis Adaptivestim |
| Alpha Orthopedic Systems | $41.34 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $41.01 | 2022-2024 | Nuzyra |
| Depuy Synthes Sales INC. | $39.84 | 2021-2022 | |
| Royal Biologics, INC. | $34.52 | 2024 | |
| Abbott Laboratories | $34.08 | 2023 | Proclaim, Eterna |
| Lifenet Health | $27.92 | 2023 | |
| Djo, LLC | $27.23 | 2023 | Cmf |
| Integra Lifesciences Corporation | $25.29 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mimedx Group, INC. | $16.83 | 2025 | |
| Amgen INC. | $15.55 | 2024 | Krystexxa |
| Nabriva Therapeutics, Plc | $15.36 | 2021 | |
| Horizon Therapeutics Plc | $15.13 | 2022 | |
| Sanara Medtech INC. | $14.41 | 2024 | Celleraterx |
| Hartmann USA, INC. | $13.96 | 2025 | Zetuvit Plus 10x10 P10 |
| Cashflow Solutions, LLC | $13.16 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Advanced Oxygen Therapy INC. | $11.42 | 2025 | Topical Oxygen Chamber For Extremities |
| Orthofix Medical, INC. | $10.24 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dalby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.